REFERENCES
1. Huston T, Pressman P, Moore A. The presentation of contralateral axillary lymph node metastases from breast carcinoma: a clinical management dilemma. Breast J 2007;13:158-64.
2. Morcos B, Jaradat I, El-Ghanem M. Characteristics of and therapeutic options for contralateral axillary lymph node metastasis in breast cancer. EJSO 2011;37:418-21.
3. Chkheidze R, Sanders M.A, Haley B. Isolated contralateral axillary lymph node involvement in breast cancer represents a locally advanced disease not distant metastases. Clin Breast Cancer 2017.
4. Kiluk J, Prowler V, Lee M.C. Contralateral axillary nodal involvement from invasive breast cancer. Breast J 2014;23:291-4.
5. Perre CI, Hoefnagel CA, Kroon BB. Altered lymphatic drainage after lymphadenectomy or radiotherapy of the axilla in patients with breast cancer. Br. J. Surg 1996;83:1258.
6. van der Ploeg I, Oldenburg H, Rutgers E. Lymphatic drainage patterns from the treated breast. Ann Surg Oncol 2010;17:1069-75.
7. Allweis T, Parson B, Klein M. Breast cancer draining to bilateral axillary lymph nodes. Surgery 2003;134:506-8.
8. Wang W, Yuan P, Wang J, et al. Management of contralateral axillary lymph node metastasis from breast cancer: a clinical dilemma. Tumori 2014;100:600-4.
9. Buchanan C, Morris E, Dorn P. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer. Ann Surg Oncol 2005;12:1045-53.
10. Amin MB, Edge S. AJCC cancer staging manual. 8th ed. Springer; 2017.
11. Moossdorff M, Vugts G, Maaskant-Braat AJ, Strobbe LJ, Voogd AC, et al. Contralateral lymph node recurrence in breast cancer: regional event rather than distant metastatic disease. A systematic review of the literature. Eur J Surg Oncol 2015;41:1128-36.
12. Cutuli B, Kanoun S, Tunon De Lara C. Breast cancer occurred after Hodgkin’s disease: Clinico-pathological features, treatments and outcome: analysis of 214 cases. Crit Rev Oncol Hematol 2012;81:29-37.
